Re: Switch to Abobotulinum Toxin A May be Useful in the Treatment of Neurogenic Detrusor Overactivity when Intradetrusor Injections of Onabotulinum Toxin A Failed Editorial Comment

被引：0
|
作者：
Wein, Alan J.
机构：
来源：
JOURNAL OF UROLOGY | 2019年 / 201卷 / 03期
关键词：
D O I：
10.1097/01.JU.0000553734.37603.c9
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：451 / 452
页数：2
相关论文
共 50 条
  • [1] SWITCH TO ABOBOTULINUM TOXIN A MAY BE USEFUL IN THE TREATMENT OF NEUROGENIC DETRUSOR OVERACTIVITY WHEN INTRADETRUSOR INJECTIONS OF ONABOTULINUM TOXIN A FAILED
    Peyronnet, Benoit
    Bottet, Florie
    Boissier, Romain
    Manunta, Andrea
    Reiss, Benedicte
    Previnaire, Jean-Gabriel
    Kerdraon, Jacques
    Ruffion, Alain
    Lenormand, Loic
    Perrouin-Verbe, Brigitte
    Gaillet, Sarah
    Game, Xavier
    Karsenty, Gilles
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1261 - E1262
  • [2] Switch to Abobotulinum toxin A may be useful in the treatment of neurogenic detrusor overactivity when intradetrusor injections of Onabotulinum toxin A failed
    Bottet, Florie
    Peyronnet, Benoit
    Boissier, Romain
    Reiss, Benedicte
    Previnaire, Jean G.
    Manunta, Andrea
    Kerdraon, Jacques
    Ruffion, Alain
    Lenormand, Loic
    Verbe, Brigitte Perrouin
    Gaillet, Sarah
    Game, Xavier
    Karsenty, Gilles
    NEUROUROLOGY AND URODYNAMICS, 2018, 37 (01) : 291 - 297
  • [3] Editorial Comment: Solifenacin treatment after intradetrusor injections with botulinum toxin in patients with neurogenic detrusor overactivity
    Averbeck, Marcio Augusto
    INTERNATIONAL BRAZ J UROL, 2022, 48 (06): : 988 - 989
  • [4] DETRUSOR INJECTIONS OF ONABOTULINUM TOXIN A (BOTOX®) VERSUS ABOBOTULINUM TOXIN A (DYSPORT®) IN THE MANAGEMENT OF NEUROGENIC DETRUSOR OVERACTIVITY : A CASE CONTROL STUDY
    Peyronnet, Benoit
    Evelyne, Castel-Lacanal
    Mathieu, Roumiguie
    Philippe, Marque
    Pascal, Rischmann
    Xavier, Game
    JOURNAL OF UROLOGY, 2015, 193 (04): : E36 - E36
  • [5] Onabotulinum toxin injection in neurogenic detrusor overactivity: intradetrusor versus suburothelial
    Burki, J. R.
    Hamid, R.
    SPINAL CORD, 2013, 51 (09) : 725 - 725
  • [6] Onabotulinum toxin injection in neurogenic detrusor overactivity: intradetrusor versus suburothelial
    J R Burki
    R Hamid
    Spinal Cord, 2013, 51 : 725 - 725
  • [7] Re: Solifenacin Treatment After Intradetrusor Injections With Botulinum Toxin in Patients With Neurogenic Detrusor Overactivity
    Elliott, Sean P.
    JOURNAL OF UROLOGY, 2023, 209 (01): : 289 - 289
  • [8] Response to ‘Onabotulinum toxin injection in neurogenic detrusor overactivity: intradetrusor versus suburothelial’
    J Krhut
    V Samal
    D Nemec
    P Zvara
    Spinal Cord, 2013, 51 : 726 - 726
  • [9] Response to 'Onabotulinum toxin injection in neurogenic detrusor overactivity: intradetrusor versus suburothelial'
    Krhut, J.
    Samal, V.
    Nemec, D.
    Zvara, P.
    SPINAL CORD, 2013, 51 (09) : 726 - 726
  • [10] Intradetrusor Injections of Onabotulinum Toxin-A in Children With Urinary Incontinence due to Neurogenic Detrusor Overactivity Refractory to Antimuscarinic Treatment
    Tarcan, Tufan
    Akbal, Cem
    Sekerci, Cagri A.
    Top, Tuncay
    Simsek, Ferruh
    KOREAN JOURNAL OF UROLOGY, 2014, 55 (04) : 281 - 287
12345